System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Ángel Aledo-Serrano, MD, PhD is an expert in Neurology at Hospital Ruber Internacional (Spain). As of October 2026, ScienceLeadR ranks Ángel Aledo-Serrano in the top 1% of experts worldwide for Epilepsy. Ángel Aledo-Serrano has authored 105 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 2 of them ongoing. SLR score: 398 (community average: 125). How the SLR is computed.

LeadR Profile

Ángel Aledo-Serrano, MD, PhD Hospital Ruber Internacional Spain
398 ScienceLeadR Reputation 398

Unlock

Register Login
Network Map

Neurology

Subspecialties: Pediatrics - Psychiatry - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2011 - 2026
Source: PubMed

Blua Sanitas Valdebebas Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 105

Citations

Citations: 1 761 1st author: 19 Last author: 9 Unique author: 0

Main journals

Epilepsy Behav 12
Epilepsia 11
Epilepsia Open 8
Seizure 7
Front Neurol 5

Best Journals

Lancet Neurol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Effectiveness and tolerability of fenfluramine in pediatric and adult patients with developmental and epileptic encephalopathies: A multicenter, retrospective, real-world clinical-practice study.
PMID 42334048 — epilepsy, anticonvulsants, fenfluramine, seizures, therapeutics, dravet syndrome		Epilepsia20263
Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy.
PMID 41985207 — epilepsy, cannabidiol		Epilepsy Behav20260
Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.
PMID 41822692 — genes, rare diseases, classification		medRxiv20260
Continuing education course on genetic epilepsies was held by the Chilean society of epileptology.
PMID 41744316 — epilepsy, education, continuing, education		Epileptic Disord20260
Seizures in children with Dravet syndrome in extreme heat: A qualitative study of parental perspectives.
PMID 41722077 — child development, adolescent, seizures, research, neurology, cerebral palsy, temperature, extreme heat, child, dravet syndrome		Dev Med Child Neurol20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 2
Phase 4 2
N/A 1
Phase 2 1

By status:

Completed 2
Recruiting 2
Unknown 1
Withdrawn 1

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A clinical trial to evaluate efficacy and safety of Xeomin injections for preventing chronic migraine
2024-515682-34-00 — injections, safety, migraine disorders		Phase 3Recruiting2025
A clinical trial to evaluate efficacy and safety of Xeomin injections for preventing episodic migraine
2024-515715-22-00 — injections, safety, migraine disorders		Phase 3Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS